Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026)
Kura Oncology's (KURA) quarterly Amortizatization of Intangibles came in at $900000.0 in Q1 2026, down 66.19% year-on-year from $2.7 million in Q1 2025, and down 34.88% on a QoQ basis from $1.4 million in Q4 2025.
Kura Oncology (KURA) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
Kura Oncology (KURA) has 12 years of Amortizatization of Intangibles data on file, last reported at $900000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 66.19% year-over-year to $900000.0 in Q1 2026; TTM through Mar 2026 was $6.7 million, a 46.33% decrease from a year earlier, with the FY2025 full-year figure at $8.5 million, down 35.41% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $900000.0, down from $1.4 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for KURA reached as high as $3.5 million in Q2 2024 and fell as low as -$1.1 million in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $1.8 million across 5 years, with a median of $2.1 million in 2023.
- Across the five-year window, Amortizatization of Intangibles surged 881.08% in 2023 and plunged 66.19% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $654000.0 in 2022, then soared by 317.89% to $2.7 million in 2023, then gained by 5.56% to $2.9 million in 2024, then plunged by 52.1% to $1.4 million in 2025, then sank by 34.88% to $900000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $900000.0 in Q1 2026, $1.4 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Kura Oncology | 916.67 Mn | 916.67 Mn | 18.00 Mn | 900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 900,000.00 |
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.66 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Dec 31, 2023 | 2.73 Mn |